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A B S T R A C T
Canine leishmaniosis (CL) is a severe and potentially fatal zoonosis caused by the protozoan Leishmania
infantum. Severe forms of CL are commonly associated with a non-protective, humoral immune-
response and high parasitic loads. Leptin, a 16 kD hormone mainly secreted by adipocytes, regulates both
the innate and adaptive immunity. The goal of this study was to evaluate leptin mRNA expression levels
in blood samples from privately owned dogs with CL (n = 11) and healthy controls (n = 10) using quan-
titative, real-time polymerase chain reaction. Blood samples from dogs with CL expressed signiﬁcantly
higher leptin mRNA levels (two-fold) compared to healthy controls (P = 0.018). The results suggest a pos-
sible involvement of leptin in the pathophysiology of Leishmania infection in dogs and the possible use
of leptin as a biomarker for CL. Future studies investigating the immunological role of leptin in dogs with
CL are warranted.
© 2014 Elsevier Ltd. All rights reserved.
Canine leishmaniosis (CL) is a severe and potentially fatal zoo-
nosis caused by the protozoan Leishmania infantum. Clinically CL is
very polymorphic and may manifest as a subclinical or severe sys-
temic disease (Bottero et al., 2006). Presentation can range from
mild dermatitis associated with speciﬁc cellular immunity
(Saridomichelakis and Koutinas, 2014), to a severe systemic disease
characterized by renal failure, a non-protective humoral immune-
response, and a reduced T helper (Th) cell-mediated immune
response (Saridomichelakis and Koutinas, 2014).
Biological molecules and their ability to orchestrate the Th1/
Th2 immune response have been widely investigated in the past
few years for their potential use as therapies for infectious dis-
eases. Leptin is a 16 kD hormone secreted primarily by adipose tissue,
but also by the stomach, skeletal muscle, placenta, memory T cells
and macrophages (Procaccini et al., 2014). Leptin has multiple phys-
iological roles, including control of energy balance and body growth,
renal function, haematopoiesis, reproduction, and immune func-
tion (Agarwal et al., 2009). Immunologically, leptin activates naïve
(CD4+CD45RA+) T cells and inhibits memory (CD4+CD45RO+) and reg-
ulatory (Foxp3+CD4+CD25high) T cells (Procaccini et al., 2014). Leptin
also promotes the polarization of Th cells towards a Th1 lineage,
thereby increasing the production of interferon (IFN)-γ and tumour
necrosis factor (TNF)-α (Procaccini et al., 2014).
Regulatory T cells (Treg) secrete leptin, but also express high levels
of leptin receptors regulating their own activation in an autocrine
fashion (Procaccini et al., 2014). Leptin has also been shown to in-
crease proinﬂammatory cytokines in macrophages exposed to
Leishmania spp. and to stimulate phagocytosis of the protozoan
(Gainsford et al., 1996). Overall, an increased inﬂammatory re-
sponse corresponds with disease exacerbation and the remaining
impaired Tregs are important in the regulation of disease pathol-
ogy in leishmaniosis (Ehrlich et al., 2014). Indeed, Tregs, macrophage
activation, and a proinﬂammatory state are all signiﬁcant in the
pathogenesis of CL.
The objective of this study was to evaluate the mRNA expres-
sion of leptin in leukocytes using quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR) on blood samples from dogs
with CL and from healthy control dogs. The hypothesis was that dogs
with CL will show altered transcription of the Leptin gene in leu-
kocytes, consistent with the lower levels of circulating Treg in dogs
with CL (Cortese et al., 2013) and the poor protective immunologi-
cal response to the parasite in peripheral tissues with high Treg levels
(Adalid-Peralta et al., 2011).
A total of 21 dogs were enrolled in this study, 11 diagnosed with
(but not treated for) CL, and 10 healthy control dogs (CN). The di-
agnosis of CL was performed in accordance with current guidelines
(Paltrinieri et al., 2010). In all dogs a body condition score (BCS) and
a test for infectious diseases (Canine SNAP 4Dx, IDEXX laborato-
ries) were also conducted. Peripheral blood was collected for a
complete cell blood count (CBC) and for biochemical analysis. Total
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RNA was extracted from fresh blood and converted to complemen-
tary DNA (cDNA) by reverse transcription.
Speciﬁc primers from canine leptin and canine glyceraldehyde-
3-phosphate dehydrogenase-like (GAPDH) were designed from
published mRNA GenBank gene sequences (Table 1). PCR reac-
tions were performed as previously described (Squillacioti et al.,
2011). All variables, clinical, haematological, and ΔCt
(Ctleptin − CtGAPDH) values, were subjected to normality testing. St-
udent’s unpaired t test and the Mann–Whitney test were used and
P ≤ 0.05 was considered signiﬁcant. Statistical analysis was con-
ducted using MedCalc 12.0 statistical software.
Dogs with CL included seven males (six intact) and four females
(three intact), while healthy controls dogs (CN) included ﬁve males
(all intact) and ﬁve females (all intact). The mean age (±standard
deviation) at the point of enrolment was 6.36 ± 1.69 years and
5 ± 2.41 years for the CL and CN groups, respectively. The median
BCS was 4/9 (range, 4–6) and 5/9 (range, 4–6) for the CL and CN
groups, respectively. Therewas no difference in bodyweight (P = 0.93),
age (P = 0.24), and sex (P = 0.55) distributions between the two
groups. Themore frequent clinical signs observed in CL were lymph-
adenopathy (72.7%), ocular disorders (45%), splenomegaly (45.5%),
moderate to severe generalized exfoliative dermatitis (45.5%) and
onychogryphosis (36.4%). The results of haematological param-
eters are summarized in Table 2. A signiﬁcant increase in leptinmRNA
levels (two-fold) was detected in the CL comparedwith the CN group
(P = 0.018) (Fig. 1).
Our ﬁndings show that an increase in leptin mRNA expression
levels is present in dogs with CL. There were no differences in
bodyweight and nutritional status between the two groups, ruling
out obesity as a confounding factor and conﬁrming the possible in-
volvement of leptin in the pathogenesis of protozoan diseases (Baltaci
and Mogulkoc, 2012). In addition, although our study evaluated
mRNA expression levels in leucocytes and not leptin circulating
protein levels, the results could explain the systemic inﬂammato-
ry status present in CL (La Cava and Matarese, 2004; La Cava, 2012).
Leptin is highly involved in the regulation of the immune system:
it stimulates the production of proinﬂammatory cytokines such as
interleukin (IL)-1 and IL-6, it is stimulated by these same cytokines,
and it inhibits Tregs (La Cava and Matarese, 2004; Procaccini et al.,
2014). These immunological effects may be relevant in severe forms
of CL in which alterations of the immune response (reduced cir-
culating and increased tissue Tregs) (Adalid-Peralta et al., 2011;
Cortese et al., 2013) and subsequent persistent chronic inﬂamma-
tion could be the effect of a systemic increase in leptin expression.
Because circulating leucocytes include both monocytes and lym-
phocytes, it is diﬃcult to discern exactly which cell source may be
responsible for this increase in leptin mRNA expression. Leptin in-
creased mRNA levels in circulating mononuclear cells could be due
to either an increase in total mononuclear cells (increase in mRNA
levels compared to controls) and/or to an increased leptin gene tran-
scription in Tregs. This increased transcription in turn may lead to
an increase of Tregs in peripheral tissues with lesions, resulting in
higher tissue production of leptin reﬂecting the CL immune
dysregulation in tissues.
In conclusion, although the results of this study are prelimi-
nary and limited to leptin mRNA expression in circulating
mononuclear cells, they suggest an involvement of leptin in CL.
Future studies investigating circulating leptin protein levels, the im-
munological role of leptin in dogs with CL, and the potential utility
of leptin as a biomarker of the severity of CL are warranted.
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